CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- 4 Shares withheld for taxes Chief Operating Officer gave up 2,133 shares (to pay taxes)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Shares withheld for taxes Chief Financial Officer gave up 7,033 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 3,117 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Pres., Novocure Oncology gave up 966 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Human Resources Officer gave up 752 shares (to pay taxes)
- 4 Open-market buy Chief Executive Officer bought 81,550 shares at $12.22 ($996,859)
- 4 Open-market buy Chief Financial Officer bought 20,000 shares at an average $11.59 ($231,800)
- 4 Grant or award Chief Human Resources Officer acquired 833 shares (grant or award)
- 4 Grant or award EVP, Pres., Novocure Oncology acquired 833 shares (grant or award)
- 4 Grant or award Director acquired 833 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 833 shares (grant or award)
- 4 Grant or award General Counsel acquired 769 shares (grant or award)
- 4 Grant or award Director acquired 11,215 shares (grant or award)
- 4 Grant or award Director acquired 11,215 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 11,215 shares (grant or award)
- 4 Grant or award Director acquired 11,215 shares (grant or award)
Page 3 of 39 · 780 filings